AKT1 and hepatocellular carcinoma: In conclusion, our study demonstrated that CREB3 suppressed the phosphorylation of AKT by competitively binding with INSR and promoting RBM38 transcription independently, thereby inhibiting HCC growth and metastasis (Figure 7F).